Open AccessSex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease
Author(s) -
Zuzana Zelinková,
Evelien Bultman,
Lauran Vogelaar,
Cheima Bouziane,
Ernst J. Kuipers,
C. Janneke van der Woude
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i47.6967
Subject(s) - medicine , infliximab , ulcerative colitis , inflammatory bowel disease , adalimumab , discontinuation , adverse effect , medical record , crohn's disease , adverse drug reaction , gastroenterology , disease , drug , pharmacology
To analyze sex differences in adverse drug reactions (ADR) to the immune suppressive medication in inflammatory bowel disease (IBD) patients.